{
    "clinical_study": {
        "@rank": "70655", 
        "arm_group": {
            "arm_group_label": "Operated Subjects", 
            "description": "ROIA Interbody Cage with VerteBRIDGE plating"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this combination retrospective and prospective post market study is to\n      examine the short term safety and efficacy of the ROI-A\u00ae interbody fusion device with\n      VerteBRIDGE\u00ae plates to treat single and two-level degenerative disc disease between L2 and\n      S1, with a focus on fusion rates and patient outcomes."
        }, 
        "brief_title": "Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Degenerative Disc Disease", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Diseases", 
                "Intervertebral Disk Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must have degenerative disc disease (DDD) of the lumbar spine between L2 and\n             S1\n\n          -  Subjects may have up to a Grade 1 spondylolisthesis at the involved level(s)\n\n          -  Subject must have the ROI-A\u00ae device at one level or at two contiguous levels between\n             L2 and S1 only\n\n          -  Subject should have had a minimum of 6 months non-surgical treatment prior to\n             receiving the ROI-A\u00ae device\n\n          -  Subject may have had NO MORE THAN two previous non-fusion surgeries to the lumbar\n             spine at the same levels as the ROI-A\u00ae\n\n          -  Subject must be at least 21 years of age at the time of surgery\n\n          -  Subject must be willing to signed an informed consent document and return for a 12\n             month visit\n\n        Exclusion Criteria:\n\n          -  Subject had more than Grade 1 spondylolisthesis at the operated level\n\n          -  Subject is a prisoner.\n\n          -  Subject was pregnant at the time of surgery.\n\n          -  Subject had an active infection or sepsis at the time of surgery."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects will be drawn from community surgeon practices in which the subjects have already\n        received the device and who meet the Inclusion/Exclusion criteria."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104141", 
            "org_study_id": "ROIA100"
        }, 
        "intervention": {
            "arm_group_label": "Operated Subjects", 
            "intervention_name": "ROIA Interbody Cage with VerteBRIDGE plating", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "DDD", 
            "lumbar spine", 
            "fusion rate", 
            "degenerative disc disease"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "Greater Baltimore Medical Center", 
            "last_name": "Reginald Davis, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Time to Fusion", 
            "safety_issue": "No", 
            "time_frame": "12 months after device implantation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104141"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Percentage of subjects with an improvement in Oswestry Disability Index", 
            "safety_issue": "No", 
            "time_frame": "12 mo. or more after initial date of surgery"
        }, 
        "source": "LDR Spine USA", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LDR Spine USA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}